Cargando…

New pharmaceuticals in inflammatory bowel disease

This paper complements the previously published Guidelines of the Working Group of the Polish Society of Gastroenterology and former National Consultant in Gastroenterology regarding the management of patients with Crohn's disease and ulcerative colitis. Attention was focused on the new pharmac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Łodyga, Michał, Eder, Piotr, Bartnik, Witold, Gonciarz, Maciej, Kłopocka, Maria, Linke, Krzysztof, Małecka-Panas, Ewa, Radwan, Piotr, Rydzewska, Grażyna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2015
Materias:	Special Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4631272/ https://www.ncbi.nlm.nih.gov/pubmed/26557934 http://dx.doi.org/10.5114/pg.2015.52702

Ejemplares similares

Iron deficiency anaemia in patients with inflammatory bowel disease: National Consultant for Gastroenterology Working Group Recommendations
por: Kaniewska, Magdalena, et al.
Publicado: (2014)

Biosimilar medicines – their use in the treatment of inflammatory bowel diseases. Position statement of the Working Group of the Polish National Consultant in Gastroenterology
por: Mularczyk, Aldona, et al.
Publicado: (2014)

Biosimilar biological drugs in the treatment of inflammatory bowel diseases
por: Kaniewska, Magdalena, et al.
Publicado: (2019)

Guidelines for the management of ulcerative colitis. Recommendations of the Polish Society of Gastroenterology and the Polish National Consultant in Gastroenterology
por: Eder, Piotr, et al.
Publicado: (2023)

Guidelines for the management of patients with Crohn’s disease. Recommendations of the Polish Society of Gastroenterology and the Polish National Consultant in Gastroenterology
por: Łodyga, Michał, et al.
Publicado: (2021)

The position statement of the Polish Society of Gastroenterology and the Polish National Consultant in Gastroenterology regarding the management of patients with inflammatory bowel disease during the COVID-19 pandemic
por: Łodyga, Michał, et al.
Publicado: (2020)

The introduction of the IBD Disk in Poland – a new tool for assessing disability in patients with inflammatory bowel disease
por: Eder, Piotr, et al.
Publicado: (2019)

Position statement of the Polish Society of Gastroenterology and the National Gastroenterology Consultant on vaccination against COVID-19 among patients with inflammatory bowel diseases
por: Eder, Piotr, et al.
Publicado: (2021)

Guidelines on the management of irritable bowel syndrome: In memory of Professor Witold Bartnik
por: Pietrzak, Anna, et al.
Publicado: (2018)

Social Distancing during COVID-19 Pandemic among Inflammatory Bowel Disease Patients
por: Łodyga, Michał, et al.
Publicado: (2021)

A Prospective Questionnaire-Based Study to Evaluate Factors Affecting the Decision to Receive COVID-19 Vaccination in 267 Patients with Inflammatory Bowel Disease in Poland
por: Łodyga, Michał, et al.
Publicado: (2022)

Genetic architecture differences between pediatric and adult-onset inflammatory bowel diseases in the Polish population
por: Ostrowski, Jerzy, et al.
Publicado: (2016)

Working Group Guidelines on the nursing roles in caring for patients with Crohn's disease and ulcerative colitis in Poland
por: Golik, Magdalena, et al.
Publicado: (2014)

Diagnostic and therapeutic recommendations for chronic pancreatitis. Recommendations of the Working Group of the Polish Society of Gastroenterology and the Polish Pancreas Club
por: Kadaj-Lipka, Roland, et al.
Publicado: (2018)

Determinants of Sleep Quality in Inflammatory Bowel Diseases
por: Sochal, Marcin, et al.
Publicado: (2020)

Awareness and Compliance with the Recommendations of Primary and Secondary Prevention of Cancer in Patients with Inflammatory Bowel Disease
por: Tulewicz-Marti, Edyta, et al.
Publicado: (2023)

Leukocytapheresis in patients with inflammatory bowel diseases
por: Woźniak, Małgorzata, et al.
Publicado: (2021)

Management of acute pancreatitis (AP) – Polish Pancreatic Club recommendations
por: Rosołowski, Mariusz, et al.
Publicado: (2016)

Redefining the Practical Utility of Blood Transcriptome Biomarkers in Inflammatory Bowel Diseases
por: Ostrowski, Jerzy, et al.
Publicado: (2019)

Alterations in programmed cell death mechanism and their role in the pathogenesis of inflammatory bowel diseases
por: Eder, Piotr, et al.
Publicado: (2014)

The Efficacy of Mebeverine in the Treatment of Irritable Bowel Syndrome—A Systematic Review
por: Daniluk, Jaroslaw, et al.
Publicado: (2022)

The prevalence, characteristics, and determinants of anaemia in newly diagnosed patients with inflammatory bowel disease
por: Woźniak, Małgorzata, et al.
Publicado: (2019)

Therapeutic and prophylactic management of bleeding from oesophageal and gastric varices – recommendations of the Working Group of the National Consultant for Gastroenterology
por: Rosołowski, Mariusz, et al.
Publicado: (2014)

The Use of Virtual Reality to Reduce Stress among Inflammatory Bowel Disease Patients Treated with Vedolizumab
por: Lewandowski, Konrad, et al.
Publicado: (2021)

Diagnostic and therapeutic recommendations on Helicobacter pylori infection. Recommendations of the Working Group of the Polish Society of Gastroenterology
por: Jaroń, Krzysztof, et al.
Publicado: (2023)

The importance of vitamin D in the pathology of bone metabolism in inflammatory bowel diseases
por: Krela-Kaźmierczak, Iwona, et al.
Publicado: (2015)

Biomarkers in management of inflammatory bowel disease
por: Moniuszko, Andrzej, et al.
Publicado: (2013)

The prevalence of celiac disease in patients with irritable bowel syndrome and its subtypes
por: Domżał-Magrowska, Danuta, et al.
Publicado: (2016)

Assessment of sexual dysfunction in patients with inflammatory bowel disease
por: Szydlarska, Dorota, et al.
Publicado: (2019)

Quality of life and depression in patients with irritable bowel syndrome
por: Kopczyńska, Magdalena, et al.
Publicado: (2018)

Pancreatic cyst fluid analysis for differential diagnosis between benign and malignant lesions
por: TALAR-WOJNAROWSKA, RENATA, et al.
Publicado: (2013)

Bone Metabolism Alteration in Patients with Inflammatory Bowel Disease
por: Tulewicz-Marti, Edyta Maria, et al.
Publicado: (2022)

Sex- and Age-Related Estrogen Signaling Alteration in Inflammatory Bowel Diseases: Modulatory Role of Estrogen Receptors
por: Jacenik, Damian, et al.
Publicado: (2019)

Bone Metabolism and the c.-223C > T Polymorphism in the 5′UTR Region of the Osteoprotegerin Gene in Patients with Inflammatory Bowel Disease
por: Krela-Kaźmierczak, Iwona, et al.
Publicado: (2016)

Management of anemia in inflammatory bowel disease: a challenge in everyday clinical practice
por: Tulewicz-Marti, Edyta, et al.
Publicado: (2017)

Guidelines for Clostridium difficile infection in adults
por: Kukla, Michał, et al.
Publicado: (2020)

The Role of Adipose Tissue in the Pathogenesis and Therapeutic Outcomes of Inflammatory Bowel Disease
por: Eder, Piotr, et al.
Publicado: (2019)

Selected Aspects of Nutrition in the Prevention and Treatment of Inflammatory Bowel Disease
por: Panufnik, Paulina, et al.
Publicado: (2022)

Serum Levels of Chemerin in Patients with Inflammatory Bowel Disease as an Indicator of Anti-TNF Treatment Efficacy
por: Sochal, Marcin, et al.
Publicado: (2021)

Associations of Lifestyle Factors with Osteopenia and Osteoporosis in Polish Patients with Inflammatory Bowel Disease
por: Rychter, Anna Maria, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7da54rkcfukniq68rc7g8ma75n